Abbott Laboratories vs. Rafael Holdings, Inc. Class B Common Stock
ABT
Abbott Laboratories
$108.79 -1.52%
VS RFLRafael Holdings, Inc. Class B Common Stock
$2.47 -1.59%
Abbott Laboratories (ABT) comes out ahead, leading on 7 of 9 compared factors.
Size & Scale
| ABT | RFL | |
|---|---|---|
| Market Cap | $191.16 billion | $130.52 million |
| Revenue (TTM) | $46.59 billion | $980,000 |
| Net Income (TTM) | $5.42 billion | $-19,312,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | RFL | |
|---|---|---|
| P/E Ratio | 35.21 | — |
| Price / Book | 3.69 | 1.62 |
| Price / Sales | 4.10 | 133.18 |
ABT and RFL split the valuation factors evenly.
Profitability
| ABT | RFL | |
|---|---|---|
| Net Margin | 11.65% | -1970.61% |
| Return on Equity | 10.48% | -23.90% |
ABT leads on 2 of 2 profitability factors.
Dividend
| ABT | RFL | |
|---|---|---|
| Dividend Yield | 2.32% | 3.27% |
| Payout Ratio | 81.55 | — |
RFL leads on 1 of 1 dividend factors.
Risk & Sentiment
| ABT | RFL | |
|---|---|---|
| Short Interest | 0.57% | 2.78% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, RFL overview, RFL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.